Glenmede Trust’s MacroGenics MGNX Stock Holding History

Glenmede Trust’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-147	Closed	-$3K	–	1818
2020 Q3	$3K	Sell	147 -210	-59%	-$5.73K	﹤0.01%	2191
2020 Q2	$9K	Sell	357 -600	-63%	-$10.4K	﹤0.01%	1912
2020 Q1	$10K	Hold	957	–	–	﹤0.01%	2426
2019 Q4	$10K	Buy	957 +172	+22%	+$1.7K	﹤0.01%	2426
2019 Q3	$10	Sell	785 -212	-21%	-$3.05K	﹤0.01%	2351
2019 Q2	$16	Hold	997	–	–	﹤0.01%	2149
2019 Q1	$17	Buy	+997	New	+$17.2K	﹤0.01%	2141

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Glenmede Trust's MGNX Position: Q4 2020 in Review

Glenmede Trust sold out of MacroGenics (MGNX) in Q4 2020, closing a stake of 147 shares — an estimated $3K sold.

Glenmede Trust first reported a position in MGNX in Q1 2019 and held it in 7 quarters. The position peaked at $10K in Q1 2020. 147 funds tracked by Wall St. Rank hold MGNX as of Q4 2020.

Glenmede Trust reported no remaining MacroGenics position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 147 MacroGenics shares in Q4 2020, an estimated $3K.
Glenmede Trust first reported a position in MacroGenics in Q1 2019 and held it in 7 quarters.
Glenmede Trust's MacroGenics position peaked at $10K in Q1 2020.
147 funds tracked by Wall St. Rank held MacroGenics as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.